Chemoinformaics analysis of 2,2,4-trimethyloctan-3-one
| Molecular Weight | 170.296 | nRot | 4 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 1 |
| Exact Molecular Weight | 170.167 | nRing | 0 |
| Solubility: LogS | -3.45 | nHRing | 0 |
| Solubility: LogP | 3.677 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 33.8414 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.631 |
| Synth | 2.803 |
| Natural Product Likeliness | 0.349 |
| NR-PPAR-gamma | 0.042 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.764 |
| Pgp-sub | 0.001 |
| HIA | 0.014 |
| CACO-2 | -4.424 |
| MDCK | 0.0000139 |
| BBB | 0.888 |
| PPB | 0.946383 |
| VDSS | 1.491 |
| FU | 0.0750504 |
| CYP1A2-inh | 0.715 |
| CYP1A2-sub | 0.912 |
| CYP2c19-inh | 0.472 |
| CYP2c19-sub | 0.93 |
| CYP2c9-inh | 0.363 |
| CYP2c9-sub | 0.821 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.659 |
| CYP3a4-inh | 0.18 |
| CYP3a4-sub | 0.331 |
| CL | 9.535 |
| T12 | 0.732 |
| hERG | 0.011 |
| Ames | 0.014 |
| ROA | 0.191 |
| SkinSen | 0.117 |
| Carcinogencity | 0.165 |
| EI | 0.942 |
| Respiratory | 0.912 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.700696 |